Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
Recruiting now · Not applicable
Conditions studied: Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
In brief
This is a small-scale micro-randomized clinical trial of a new mobile just-in-time adaptive intervention (JITAI) designed to promote oral chemotherapy adherence in adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL). The goals of this study are to determine intervention feasibility and acceptability.
Key facts
- Study ID
- NCT03932903
- Run by
- Northwestern University
- People needed
- 60
- Starts
- 2025-07-31
- Expected to finish
- 2027-08-31
- Last updated by the study team
- 2026-06-30
Who can join
Age: 14 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.